Bill

Bill > HR6779


US HR6779

US HR6779
Using Data to Prevent Opioid Diversion Act of 2018


summary

Introduced
09/12/2018
In Committee
09/12/2018
Crossed Over
Passed
Dead
12/31/2018

Introduced Session

115th Congress

Bill Summary

Using Data to Prevent Opioid Diversion Act of 2018

AI Summary

This bill aims to provide drug manufacturers and distributors with access to anonymized information through the Automated Reports and Consolidated Orders System (ARCOS) to help them identify, report, and stop suspicious orders of opioids and reduce diversion rates. The key provisions of the bill include: 1. Requiring the Attorney General to make certain information available to manufacturers and distributors through ARCOS, such as the total number of distributors that distribute controlled substances to a pharmacy or practitioner, and the total quantity and type of opioids distributed to each pharmacy and practitioner. 2. Allowing the Attorney General to take into account the information made available through ARCOS when determining whether to initiate proceedings against a registered manufacturer or distributor for failing to maintain effective controls against diversion. 3. Requiring the Attorney General to prepare and make available to state regulatory, licensing, attorney general, and law enforcement agencies a standardized report containing information on the actual distribution patterns of certain controlled substances in schedule II. 4. Increasing civil and criminal penalties for registered manufacturers or distributors of opioids who fail to review the most recent information made available by the Attorney General through ARCOS. 5. Defining the term "suspicious order" and requiring registrants to design and operate a system to identify suspicious orders, and report such orders to the Drug Enforcement Administration. 6. Requiring the Attorney General to establish a centralized database for collecting reports of suspicious orders, and to share information about suspicious orders with the states. The overall goal of the bill is to improve the ability of the government and drug manufacturers and distributors to identify and stop the diversion of opioids, which has contributed to the opioid epidemic in the United States.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (on 09/12/2018)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...